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 23 
Abstract 24 
 25 
Enteric redmouth disease (ERM or yersiniosis) is one of the most important diseases of 26 
salmonids and leads to significant economic losses. It is caused by the Gram-negative 27 
bacterium Yersinia ruckeri but can be controlled by bacterin vaccination. The first 28 
commercial ERM vaccine was licenced in 1976 and is one of the most significant and 29 
successful health practices within the aquaculture industry. Although ERM vaccination 30 
provides complete protection, knowledge of the host immune response to the vaccine and the 31 
molecular mechanisms that underpin the protection elicited is limited. In this report, we 32 
analysed the expression in spleen and gills of a large set of genes encoding for cytokines, 33 
acute phase proteins (APPs) and antimicrobial peptides (AMPs) in response to ERM 34 
vaccination in rainbow trout, Oncorhynchus mykiss. Many immune genes in teleost fish are 35 
known to have multiple paralogues that can show differential responses to ERM vaccination, 36 
highlighting the necessity to determine whether all of the genes present react in a similar 37 
manner. ERM vaccination immediately activated a balanced inflammatory response with 38 
correlated expression of both pro- and anti-inflammatory cytokines (eg IL-1β1-2, TNF-α1-3, 39 
IL-6, IL-8 and IL-10A etc.) in the spleen. The increase of pro-inflammatory cytokines may 40 
explain the systemic upregulation of APPs (eg serum amyloid A protein and serum amyloid 41 
protein P) and AMPs (eg cathelicidins and hepcidin) seen in both spleen and gills. We also 42 
observed an upregulation of all the α-chains but only one β-chain (p40B2) of the IL-12 family 43 
cytokines, that suggests specific IL-12 and IL-23 isoforms with distinct functions might be 44 
produced in the spleen of vaccinated fish. Notably the expression of Th1 cytokines (IFN-γ1-45 
2) and a Th17 cytokine (IL-17A/F1a) was also up-regulated and correlated with enhanced 46 
expression of the IL-12 family α-chains, and the majority of pro- and anti-inflammatory 47 
cytokines, APPs and AMPs. These expression profiles may suggest that ERM vaccination 48 
activates host innate immunity and expression of specific IL-12 and IL-23 isoforms leading 49 
to a Th1 and Th17 biased immune response. A late induction of Th2 cytokines (IL-4/13B1-2) 50 
was also observed, that may have a homeostatic role and/or involvement in antibody 51 
production. This study has increased our understanding of the host immune response to ERM 52 
vaccination and the adaptive pathways involved. The early responses of a set of genes 53 
established in this study may provide essential information and function as biomarkers in 54 
future vaccine development in aquaculture. 55 
 56 
Key words: Enteric redmouth disease, vaccination, cytokine, acute phase protein, 57 
antimicrobial peptide, gene expression, T helper 1, T helper 17, spleen, rainbow trout,   58 
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1. Introduction 59 
 Enteric redmouth disease (ERM, yersiniosis) is one of the most important diseases of 60 
salmonids and leads to significant economic losses [1-2]. The disease is caused by Yersinia 61 
ruckeri, a Gram-negative rod-shaped enterobacterium, first isolated from rainbow trout 62 
Oncorhynchus mykiss in the Hagerman Valley of Idaho, USA in the 1950s [3-5]. ERM 63 
infected rainbow trout show a general septicaemia with an inflammatory response in all 64 
tissues. The gills are the first route of entry for infection, with the spleen a major secondary 65 
lymphoid organ associated with the response [1,6].  66 
 67 
Vaccination as a means of controlling ERM is one of the most significant and successful 68 
health practices within the aquaculture industry, and has helped to reduce the use of 69 
environmental unfriendly antibiotics to control this bacterial disease [7]. The first commercial 70 
fish vaccine for ERM was licensed in 1976, and was a bacterin prepared from formalin-killed 71 
whole cells of Y. ruckeri. A simple immersion is effective but intraperitoneal (ip) injection 72 
provides superior and long lasting protection against ERM [8]. However, ERM outbreaks 73 
have occurred recently due to the emergence of atypical biotypes of Y. ruckeri [2]. This issue 74 
can be resolved by including new isolates in the improved vaccine preparation, as shown with 75 
AquaVac(®) RELERA™ that contains both biotypes 1 and 2 of Y. ruckeri and provides 76 
better protection [8-9]. Moreover, distinct strains of Y. ruckeri are present in the environment 77 
and can evolve with the introduction of susceptible hosts and vaccination of salmonids in 78 
aquaculture [10-11]. As the production of global aquaculture continues to increase it is likely 79 
that vaccines against other bacterial disease will encounter similar issues and will need the 80 
development of improved formulations.  81 
 82 
The development of fish vaccines has been largely empirical, based on whether a formulation 83 
is effective at increasing survival post-disease challenge [12]. This is unsatisfactory from 84 
both ethical and scientific perspectives. There is a clear need to establish methods to improve 85 
fish vaccine development, such as pre-screening of candidate vaccines in the early 86 
development phase and the quality control of vaccines. The immune system is a network of 87 
specialized cell types and tissues that communicates via cytokines and direct contact, to 88 
orchestrate specific types of responses to effect protection [13]. It is known in mammals that 89 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
 
different vaccines induce distinct transcriptional signatures, representing the highly 90 
specialized defence mechanisms that can be elicited to cope with the different pathogens and 91 
insults a host may encounter. In this context, the early innate responses to vaccines are likely 92 
critical instructors for the development of adaptive immunity at later time points [14]. For the 93 
development of new vaccines, it is crucial to determine molecular signatures of vaccine-94 
induced immune responses to gain a better understanding of the pathways involved and 95 
mechanisms that underpin protection, as well as to predict vaccine performance. 96 
 97 
As a highly efficacious vaccine, the ERM vaccine provides a useful model for the 98 
investigation of fish immune responses to vaccines and bacterial diseases. Thus past studies 99 
have examined immune gene responses to ERM after vaccination [15-16] or after vaccination 100 
and challenge [9,17-18]. However, only a relatively small number of genes were investigated 101 
in these studies and often in the absence of information of the paralogues present [15-18]. 102 
With the recent release of salmonid genomes [19-20] and the identification of a large number 103 
of cytokine genes including the paralogues for IL-1β [21], TNF-α [22], IL-17A/F [23-24], IL-104 
4/13 [25] and subunits of the IL-12 family [26-29] in salmonids, it is timely to revisit the 105 
early immune responses to ERM vaccination. 106 
 107 
Hence, in this study ERM vaccination was used as a model to investigate the early cytokine 108 
responses in rainbow trout in two major and relevant immune organs, the spleen and gills. 109 
The expression of acute phase proteins (APPs) and anti-microbial peptides (AMPs) was also 110 
examined. We found that intraperitoneal injection vaccination induces an early balanced 111 
expression of pro- and anti-inflammatory cytokines and adaptive cytokines in the spleen, with 112 
a heightened expression of APPs and AMPs in both spleen and gills. 113 
 114 
  115 
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2. Materials and Methods 116 
2.1 Fish maintenance and rearing condition 117 
Apparently healthy rainbow trout with no history of infection were purchased from the Mill 118 
of Elrich Trout Fishery (Aberdeenshire, Scotland, UK) and maintained in 1-m-diameter 119 
fibreglass tanks with recirculating freshwater at 14+1°C at the Scottish fish immunology 120 
research centre, the University of Aberdeen, UK. At least 10 fish from each batch were 121 
screened for potential bacterial infection by taking head kidney swabs and growing on tryptic 122 
soy broth (Sigma, UK) agar plates. No bacterial growth was seen. Fish were fed (2% 123 
biomass) twice a day with a commercial diet (EWOS) and given two weeks for acclimation 124 
prior to vaccination. 125 
 126 
2.2 Fish vaccination 127 
The commercial vaccine AquaVacTM ERM (MSD Animal Health), a formalin-inactivated 128 
bacterin containing not less than 5 x 109 cells per ml of Y. ruckeri (Hagerman strain type 1), 129 
was used in this study. The vaccine trial was described previously [30]. Briefly, a group of 24 130 
fish (mean ± SEM = 48.8 ± 1.5) were vaccinated by intraperitoneal injection (ip) of 0.1 ml of 131 
vaccine following manufacturer's instructions. The same number of fish were injected with 132 
phosphate buffer saline (PBS) as the control. The vaccinated and control groups were kept in 133 
separate 1-m-diameter fibreglass tanks in a single recirculating freshwater system at 14+1°C. 134 
Fish handling and experimental protocols comply with the Guidelines of the European Union 135 
Council (2010/63/EU) for the use of laboratory animals, and were carried out under UK 136 
Home Office project licence PPL 60/4013, approved by the ethics committee at the 137 
University of Aberdeen. 138 
2.3 Sampling, total RNA extraction and cDNA synthesis 139 
Six fish from both the vaccinated and control groups were killed at 1, 3, 7 and 14 days post 140 
vaccination. Spleen and gills were taken from each fish and homogenised separately in TRI 141 
reagent (Sigma, UK). Total RNA extraction and cDNA synthesis was as described previously 142 
[17, 31]. The synthesised cDNA samples were diluted in TE buffer (10 mM Tris-HCl, 1mM 143 
EDTA, pH8.0) and stored at -20°C ready for real-time PCR analysis. 144 
 145 
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2.4 Gene expression analysis by real-time PCR  146 
The expression of a set of genes for acute phase proteins (APPs), antimicrobial peptides 147 
(AMPs) and cytokines using real time PCR were performed as described previously [25,32-148 
33]. Briefly, the PCR amplification was performed using a  LightCycler® 480 Instrument II 149 
(Roche Applied Science) and 384 multiwell plates in a 10 µl reaction using SYBR® Green I 150 
(Invitrogen™, Carlsbad, USA) and IMMOLASE ™ DNA Polymerase (Bioline, UK), and 151 
expression levels calculated using the ‘LightCycler® 480 software version 1.5.  Elongation 152 
factor-1α (EF-1α), a house keeping gene, was used as an internal control. The sequences of 153 
primers used, and the DDBJ/ENA/GenBank accession number of the sequence the primers 154 
were designed against are listed for each gene in Table 1. At least one of each primer pair 155 
was designed to cross an intron and were tested to ensure that PCR products could only be 156 
amplified from cDNA samples and not from genomic DNA. The cp value (the crossing point 157 
at which the fluorescence crosses the threshold, means+SEM) of EF-1α was 11.31+0.25 158 
(spleen samples) and 10.44+0.11 (gill samples). The expression of each gene was first 159 
normalized to that of EF-1α, and expressed as a fold change relative to the expression level of 160 
control fish at the same time points. 161 
 162 
2.5 Data and statistical analysis 163 
For the statistical analysis, all of the gene expression data were first calculated as arbitrary 164 
units after normalization to the expression level of the house keeping gene EF-1α. Then the 165 
data were log2 transformed to improve the normality of real-time quantitative PCR 166 
measurements, as described previously [31]. One way-ANOVA and Bonferroni post hoc tests 167 
were used to analyse all of the expression data using IBM SPSS statistics 22 software (SPSS 168 
Inc., Chicago, IL, USA). Differences between vaccinated and control groups for each time 169 
point were considered statistically significant at p < 0.05. In addition, we also undertook a 170 
correlation analysis of vaccine modulated genes using the Spearman rank order correlation 171 
test to look for associations between expression patterns. The gene expression levels in spleen 172 
samples at day 1 and day 3 (N=12) were used for this analysis, since the majority of gene 173 
expression changes seen were during this period. 174 
  175 
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3. Results  176 
The expression of 63 genes, including the house keeping gene EF-1α, 11 APPs and AMPs, 46 177 
cytokine genes and 5 master transcription factors, were analysed by real-time RT-PCR in this 178 
study. To give an indication of relative transcription level in the spleen and gills, ∆Cp that is 179 
the Cp of the target gene minus that of EF-1α, were provided for the control fish at day 1 in 180 
Table 1.  181 
 182 
3.1 ERM-vaccination activates an immediate expression of APP and AMP genes in both 183 
spleen and gills 184 
 185 
APPs, eg serum amyloid A protein (SAA) and serum amyloid protein P (SAP), and AMPs, 186 
eg cathelicidins (CATH) and hepcidin, are evolutionarily conserved effector molecules of the 187 
innate immune system that have important roles in the resolution of infection and activation 188 
of the adaptive immune response [34-35] The expression of some APPs and AMPs has been 189 
shown to be induced by Y. ruckeri infection previously [36]. Thus their expression was 190 
examined first in response to ERM vaccination. Trout SAA was highly expressed in spleen 191 
and gills (∆Cp=8, Table 1). Its expression was significantly induced in spleen by ERM 192 
vaccination at day 1, 3 and 7, and peaked at day 1 (89-fold) and in the gills at day 1 (18-fold, 193 
Fig. 1A). One of the SAP paralogues, SAP1 that was lowly expressed constitutively, was also 194 
induced in spleen at day 1 and 3 (Fig. 1B and C). 195 
 196 
The constitutive expression of the AMPs, CATH1, CATH2 [35] and Hepcidin [34] was 197 
relatively high in spleen and gills (∆Cp=9 to 16, Table 1). CATH1 expression was induced at 198 
day 1 and day 3 in spleen but was refractory in gills after ERM vaccination (Fig. 1D). 199 
CATH2 expression was highly induced and peaked at day 1 in both spleen (385 fold) and 200 
gills (32 fold) and the heightened expression lasted until day 7 in the spleen and day 3 in the 201 
gills after vaccination (Fig. 1E). Hepcidin expression was also induced at day 1 in both 202 
spleen (43 fold) and gills (59 fold, Fig. 1F) by ERM vaccination. The expression of other 203 
AMPs, including LEAP2A [37] and β-defensins [38] was refractory in both spleen and gills 204 
(Table 2 and S1). 205 
 206 
3.2 ERM-vaccination induces an early correlated upregulation of pro- and anti-207 
inflammatory cytokine expression in the spleen 208 
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A successful vaccine is expected to activate the innate immune system to express pro- and 209 
anti-inflammatory cytokines. Several such cytokines have been investigated previously [15-210 
16]. However, many other cytokines discovered recently, especially the paralogues, have not 211 
been examined after ERM vaccination. Therefore, a large number of cytokine genes 212 
including all the known paralogues have been investigated in this study. Three active IL-1β 213 
paralogues are present in salmonids [21]. IL-1β1 and IL-1β3 have relatively high constitutive 214 
expression in spleen and gills, compared to IL-1β2 (Table 1). The expression of both IL-1β1 215 
and IL-1β2 was induced at day 1 and 3, and peaked at day 1 in the spleen (Fig. 2A-B), but 216 
was not modulated in the gills (Table S1), of vaccinated fish. IL-1β3 expression was 217 
refractory (Table 2 and S1). In terms of fold change, IL-1β2 expression was more inducible 218 
(peaked at 49 fold) than IL-1β1 (peaked at 17 fold). At least three TNF-α paralogues are 219 
present in rainbow trout [22]. All the three genes (TNF-α1-3) were up-regulated in spleen at 220 
day 1, with TNF-α2 remaining elevated at day 3 in the spleen, but no changes were seen in 221 
the gills after vaccination (Fig. 2C-E). The other pro-inflammatory cytokines investigated 222 
included IL-8 [39], and three IL-6 family members (IL-6, IL-11 and M17) [40-41]. The 223 
expression of all these genes was induced and peaked at day 1 in the spleen (Fig. 2F-I) after 224 
vaccination but in gills only IL-6 expression was induced to a small extent (3 fold) at day 225 
1(Table S1).  226 
Several genes with regulatory roles, including two paralogues of IL-10 [42] TGF-β1 [43] and 227 
FoxP3 [44], and the novel fish IL-1 family member nIL-1Fm [45] were also investigated. IL-228 
10A expression was up-regulated from days 1 and 3 and peaked at day 1 (301 fold) (Fig. 2J) 229 
in the spleen but was not modulated in the gills of vaccinated fish, however IL-10B 230 
expression was refractory in both tissues (Table 2 and S2). The expression of nIL-1Fm was 231 
also induced at day 1 in the spleen by vaccination (Fig. 2K). The expression of both TGF-β1 232 
paralogues was refractory in both spleen and gills after vaccination (Table 2 and S1). 233 
However, the expression of the two trout master transcription factors Fox3A and Fox3B, 234 
important for mammalian TGF-β1 expression in mammals, was decreased at day 1 in the gills 235 
and spleen respectively (Fig. 2L, Table 2 and S1).  236 
Correlation analysis of vaccination-modulated gene expression in the spleen at day 1 and 3 237 
revealed that the expression of the major pro-inflammatory cytokines (IL-1β1, IL-1β2, TNF-238 
α paralogues, IL-6, IL-8, IL-11 and M17) and anti-inflammatory cytokines (IL-10A and nIL-239 
1Fm) was highly correlated (Table 3). Their expression was also correlated with that of APPs 240 
(SAA) and AMPs (CATH1, CATH2 and hepcidin) (Supplementary Table. S2). 241 
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 242 
3.3 ERM-vaccination activates an early Th1 and Th17-type response but a later Th2-243 
type response in the spleen 244 
Activation of specific Th responses is important for vaccine-mediated immunity [46]. The 245 
expression of the key Th-response specifying cytokines has only focused on IFN-γ1 after 246 
ERM vaccination to date [15-16]. With the recent success of identification of the complete 247 
repertoire of these cytokines, including three IL-4/13 paralogues and six IL-17A/F paralogues 248 
[24-25] in rainbow trout, we examined, for the first time, the repertoire of Th response related 249 
cytokines after ERM vaccination. The Th1 specifying cytokines, IFN-γ1 and IFN-γ2 were 250 
induced at day 1 (8 fold) in the spleen of vaccinated fish (Fig. 3A-B). Two IFN-γ inducing 251 
cytokines, IL-18 [47] and IL-21 [31] were also significantly induced to some extent at day 1 252 
in the spleen, but not in the gills, of the vaccinated fish (Table 2 and S1). Of the six potential 253 
Th17 cytokines in rainbow trout, the expression of IL-17A/F1A, 2A and 3 was upregulated at 254 
day 1 in spleen, with IL-17A/F2A remaining elevated at day 3, but no changes were apparent 255 
in the gills of vaccinated fish (Fig. 3E-G). However, IL-17A/F1B, 2B and IL-17N (or IL-256 
17A/F4) were refractory (Table 2 and S1). In terms of inducibility, IL-17A/F1A (105 fold) 257 
and 17A/F3 (19 fold) were more responsive than IL-17A/F2A (7 fold). Three potential Th2 258 
cytokines, IL-4/13A, IL-4/13B1 and IL-4/13B2 are present in salmonids [25]. A small but 259 
significant induction of the expression of IL-4/13B1 (4 fold) and IL-4/13B2 (3 fold) was 260 
found at day 3 only in the spleen of vaccinated fish (Fig. 3J-K). IL-4/13A expression was 261 
refractory (Fig. 3I), as was the expression of the master transcription factors (T-bet, GATA3 262 
and RORγ) [48-49] and the T cell cytokine IL-2 [50] (Fig. 3C, D, H, and L) in the spleen. Of 263 
these genes only RORγ at day 14 was modulated in the gills but again to a very small degree 264 
(Table S2).  265 
 266 
The expression of Th1 cytokines (IFN-γ1 and 2) and the Th17 cytokines (IL-17A/F1A and 267 
IL-17/A/F3) was highly correlated (R=0.72-0.90, p<0.001) but there was a lack of correlation 268 
with the other Th17 cytokine IL-17A/F2A, and the Th2 cytokine IL-4/13B1, the 269 
predominantly expressed IL-4/13B isoform (Table 4). The expression of IFN-γ1, IFN-γ2 and 270 
IL-17A/F1A was also correlated to IL-21, the majority of pro-inflammatory cytokines (IL-271 
1β1-2, TNF-α1-3, IL-6, IL-8, IL-11 and M17), anti-inflammatory cytokines (IL-10A and nIL-272 
1Fm), APPs and AMPs (Table S2).  273 
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 274 
3.4 ERM-vaccination induces specific isoforms of the IL-12 family members in the 275 
spleen  276 
IL-12 family cytokines play key roles in immunity bridging the innate and adaptive immune 277 
systems. Each cytokine consists of an α-chain (p19, p28 and p35), and a β-chain (p40 and 278 
EBI3) in mammals. The orthologues of mammalian p35 and p40 are increased in teleosts 279 
fish, and salmonids in particular, due to the whole genome duplication events in these 280 
lineages [25]. Rainbow trout has three isoforms of p35 and p40, and two p28 isoforms, that 281 
potentially make additional IL-12 family cytokines [51]. The constitutive expression of α-282 
chains (p35A1, p35A2, p35B1, p19, p28A and p28B) was lower (∆Cp=16-22, Table 1) than 283 
that of the β-chains (P40A, P40B2, p40C and EBI3, ∆Cp=9-17, Table 1). The expression of 284 
all the α-chains was significantly increased in spleen and peaked at day 1 (13.6-fold for 285 
p35A1, 37.5-fold for p35A2, 58.7-fold for p35B1, 1502.0-fold for p19, 52.6-fold for p28A 286 
and 11.1-fold for p28B), with upregulated levels remaining at day 3 except for p35A1 and 287 
p28B, in the spleen (Fig. 4A-E). No modulation of these genes occurred in the gills and 288 
expression of the β-chains was refractory in both spleen and gills, with the exception of 289 
p40B2 that was up-regulated 3.4-fold at day 1 in the spleen (Fig. 5F, Table 2 and S1). These 290 
expression profiles suggest that specific isoforms of IL-12 and IL-23 could be increased in 291 
the spleen after ERM vaccination. 292 
 293 
The upregulated expression of the α-chains in the spleen was significantly correlated and also 294 
correlated to that of Th1 (IFN-γ1/2) and Th17 (IL-17A/F1A) markers (Table 4). The 295 
increased expression of most of the IL-12 family α-chains was also correlated to the pro-and 296 
anti-inflammatory cytokines (IL-1β1-2, TNF-α1-3, IL-6, IL-8, IL-11, M17, IL-21, nIL-1Fm 297 
and IL-10A), AMPs (CATH1, CATH2 and hepcidin) and APPs (SAA and SAP1, Table S2). 298 
 299 
3.5 Other cytokine genes  300 
Other cytokine genes examined included IL-15 [52], two IL-17C paralogues [53], IL-20 [54], 301 
IL-22 [55] and IL-34 [56] and were refractory in both spleen and gills in response to ERM 302 
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vaccination (Table 2 and S1). IL-17D, which was lowly expressed in the spleen, was 303 
inhibited at day 3 in the spleen of vaccinated fish (Table 2).  304 
305 
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4. Discussion 306 
Through the analysis of the expression of a large number of immune genes after ERM 307 
injection vaccination in rainbow trout, we observed a systematic activation of anti-microbial 308 
defences in both spleen and gills, but a specific activation of inflammatory cytokines and 309 
specific IL-12 family members that leads to a Th1/Th17 biased immune activation in the 310 
spleen.  311 
 312 
4.1 Activation of pro- and anti-inflammatory cytokines in the spleen after ERM 313 
vaccination 314 
In this study, we comparatively examined immune gene expression in spleen and gills after 315 
ERM vaccination. The choice of spleen over head kidney was because transcriptome changes 316 
mainly happen transiently in spleen after bacterin vaccination in fish as shown by microarray 317 
analysis [57]. The gill tissue was chosen because it is a major lymphoid tissue in salmonids 318 
[58] and an important immune organ relevant to bacterial infections such as ERM [1, 2, 6]. 319 
Vaccination with a bacterin mimics a bacterial infection thereby activating the innate immune 320 
system and initiating an adaptive immune response without the development of severe 321 
disease. Thus, a number of genes known to be activated by Y. ruckeri infection (Table 5) 322 
were found to be activated by ERM vaccination in this study. However, key differences of 323 
the host responses between ERM vaccination and Y. ruckeri infection exist. First, only a 324 
subset of genes are commonly activated by both ERM vaccination and infection. For 325 
example, the major pro-inflammatory cytokines IL-1β1-2, TNF-α1-3, IL-6, IL-8, IL-17A/F 326 
(1A, 2A and 3) and IFN-γ1, and anti-inflammatory cytokine IL-10A were activated by both 327 
vaccination and infection. In contrast, IL-2, IL-17C1-2 and TGF-β1A were up-regulated only 328 
by infection and were refractory to vaccination (Table 5). Secondly, the kinetics of gene 329 
activation was different. For example, the activation of gene expression by ERM vaccination 330 
was rapid and peaked at day 1 for most of the genes, whilst during infection the activation of 331 
inflammatory genes such as IL-1β, TNFα, and SAA occurs later [36]. Thirdly, the activation 332 
of pro- and anti-inflammatory cytokine expression happened mainly in the spleen by 333 
vaccination but also in the gills by infection (Table 5). Although direct comparisons of 334 
transcript levels between different experiments could be complicated by multiple factors, 335 
such as the age and life history of the fish, and the pathogen strains used, these comparisons 336 
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do suggest that different pathways have been activated by vaccination and pathogenic 337 
challenge. 338 
 339 
The differences between ERM vaccination and pathogenic Y. ruckeri infection observed 340 
could be attributed to (1) dose effects, (2) factors released during infection [2,3] but absent in the 341 
vaccine preparation, (3) different stress responses due to the damage caused by pathogenic 342 
infection and vaccination, and (4) the evasion mechanisms of the pathogen. The ERM 343 
vaccination used a high dose, ie equivalent to 5x108 cfu/fish, whilst infection studies typically 344 
use lower doses, eg 5x105 cfu/fish [17, 45]. It is well known that the host immune response 345 
(eg cytokine transcript levels) is dose (pathogen load) dependent [36]. Thus, after ERM 346 
vaccination we observed an immediate activation of a set of APPs, AMPs, and pro- and anti-347 
inflammatory cytokines in the spleen. However, after low(er) dose infection, the bacteria 348 
multiply and spread in different target tissues, with associated tissue damage likely 349 
responsible for the relatively late kinetics of gene expression and the broad activation of 350 
immune genes in multiple tissues (eg in both the spleen and gills). Some of the differences, 351 
however, might be due to immune evasion of the pathogen. For example, IL-4/13B1-2 were 352 
shown to be induced in vitro in HK cells by bacterin exposure and in vivo in the spleen after 353 
vaccination. In contrast, their expression was inhibited in gills by Y. ruckeri infection [25]. 354 
 355 
Despite the differences, the expression of the major pro-inflammatory cytokines (IL-1β1, IL-356 
1β2, and TNF-α paralogues, IL-6, IL-8, IL-11 and M17) and anti-inflammatory cytokines 357 
(IL-10A and nIL-1Fm) was highly upregulated in the spleen (but not in the gills) immediately 358 
after ERM vaccination (Figs. 2-3). These changes are highly correlated (Table 3), suggesting 359 
an effective activation of the innate immune system was established with a balanced 360 
inflammatory response. 361 
 362 
4.2 Activation of IL-12 family cytokines may lead to a Th1/Th17 biased adaptive 363 
immune response  364 
Among a wide range of cytokines, the IL-12 family (IL-12, IL-23, IL-27 and IL-35) has 365 
unique structural, functional, and immunological characteristics that have made this family as 366 
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important immunological playmakers. Each IL-12 family member is composed of an α-chain 367 
(p19, p28 and p35) and a β-chain (p40 and Ebi3). Whilst IL-12 (p35/p40), IL-23 (p19/p40) 368 
and IL-27 (p28/EBI3) are secreted by activated antigen presenting cells (APC) during antigen 369 
presentation to naïve T cells, IL-35 (p35/EBI3) is a product of regulatory T and B cells  in 370 
mammals [26, 60-61]. IL-12 and IL-23 are proinflammatory or prostimulatory cytokines, 371 
whereas IL-27 and IL-35 are inhibitory cytokines. With our recent success in cloning and 372 
characterizing all of the subunits of the IL-12 family in salmonids [26-29], this is the first 373 
study to examine their involvement in a fish vaccination model. Although the constitutive 374 
expression of α-chains (p35A1, p35A2, p35B1, p19, p28A and p28B) was low, their 375 
expression was significantly increased in the spleen of vaccinated fish. The expression of the 376 
β-chain p40B2 was also up-regulated, but not p40B1, p40C or EBI3. This expression profiles 377 
suggest that specific isoforms of IL-12 and IL-23 containing p40B2 could be produced in the 378 
spleen after ERM vaccination. 379 
 380 
CD4+ T cells, also known as T-helper (Th) cells, play an important role in orchestrating 381 
adaptive immune responses to pathogens and vaccines. When naive CD4+ T cells recognize a 382 
foreign antigen-derived peptide presented in the context of major histocompatibility complex 383 
(MHC) class II on APCs, they undergo massive proliferation and differentiation into distinct 384 
Th cell subsets such as Th1, Th2, Th17 and induced T-regulatory (iTreg) cells in mammals 385 
[46]. Whilst IL-12 and IL-23 are critical for Th1 and Th17 cell development, respectively, 386 
IL-35 has immunosuppressive effects that are mediated through regulatory T and B cells. IL-387 
27 displays both pro- and anti-inflammatory activities. It promotes the differentiation of Th1 388 
and IL-10-producing Tr1-like regulatory cells, but inhibits Th2 and Th17 [62]. Whilst the 389 
extent to which the mammalian Th cell paradigm is conserved is still unclear in fish [46], it 390 
provides a framework to investigate the immune responses to vaccination in fish [63-64]. The 391 
expression of Th1 cytokines (IFN-γ1 and 2), Th17 cytokines (IL-17A/F1A, 2A and 3), and 392 
Th2 cytokines (IL-4/13B1 and 2) was increased in the spleen after ERM vaccination. It is 393 
notable that the increased expression of IFN-γ1 and 2, and IL-17A/F1A was earlier and 394 
higher than Th2 cytokines (Fig. 4). Furthermore, their upregulated expression was 395 
significantly correlated to that of the α-chains of the IL-12 family, and pro-/anti-inflammatory 396 
cytokines in the spleen of the vaccinated fish (Table 4). It is known that rainbow trout IL-12 397 
isoforms can induce IFN-γ expression [26]. The correlated expression of IL-12 and IL-23 398 
with Th1 and Th17 cytokines and pro-anti-inflammatory cytokines may suggest that ERM 399 
vaccination activates a balanced inflammatory response with the expression of IL-12 and IL-400 
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23 leading to a Th1 and Th17 biased immune response in the spleen. The ability of IL-23 to 401 
induce Th17 cytokine expression remains to be proven since no bioactivity analysis of this 402 
cytokine has been performed in any fish species.  403 
 404 
In mammals the differentiation of Th cell subsets and expression of lineage specifying 405 
cytokines depend on the induction of lineage-specific master transcription factors, including 406 
T-bet for Th1, GATA3 for Th2, and RORγt for Th17 [45, 65]. Although the expression of 407 
Th1, Th2 and Th17 cytokines was found increased in the spleen of ERM vaccinated fish, the 408 
expression of T-bet, GATA3 and RORγ was refractory. However, the lack of transcriptional 409 
factor expression change at a tissue level doesn’t exclude their role in the regulation of 410 
cytokine gene expression in a specific cell type. Indeed, the master transcription factors can 411 
be expressed in other cell types in addition to Th cells, and their expression can coexist in the 412 
same cell and is dynamic and quantitative [65]. Thus at the mixed tissue level, changes of 413 
gene expression in a specific cell type(s) may be diluted by the presence of other abundant 414 
cell types or by the changes in other cell types. The possibility to isolate relevant fish 415 
leucocyte populations, such as CD4+ or CD8+ cells, and study their responses has become 416 
possible in fish recently using antibodies [66-68] or transgenic fish [69].  For example in trout 417 
infected with Y. ruckeri 4 days earlier, upregulation of Th1 (IL-2, IFN-γ) and Th17 cytokines 418 
(IL-17A/F1a, IL-21, IL-22) is apparent in splenic CD4-1+/CD4-2+ cells and CD4-1-/CD4-2+ 419 
cells [70]. Such studies will undoubtedly be directed towards elucidating the responses in 420 
vaccinated fish in the near future. 421 
4.3 Systematic activation of anti-microbial defences by ERM vaccination 422 
APPs are an integral part of the acute phase response. They are secreted by the liver in 423 
response to a variety of injuries and can also be expressed in extrahepatic tissues. APPs 424 
favour the systemic regulation of defence, coagulation, proteolysis, and tissue repair [62]. 425 
AMPs are integral components of innate immunity, and one of the first lines of host defence 426 
against bacterial infection. The up-regulation of APPs and AMPs in both spleen and gills 427 
suggests a systemic activation of innate immune system by ERM vaccination, that provide 428 
non-specific protection after vaccination. 429 
 430 
It is known that many proinflammatory cytokines can induce the expression of APPs and 431 
AMPs in mammals and in fish. In rainbow trout, IL-6 induces hepcidin and CATH2 but not 432 
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CATH1 in the macrophage cell line RTS-11[32]. In contrast TNF-α3 induces hepcidin and 433 
CATH1 but not CATH2 in HK macrophages [22], whilst IL-1β can induce the expression of 434 
both CATH1 and CATH2 (un-published results). Adaptive cytokines such as IL-4/13 can 435 
also induce APPs (eg SAP1), and AMPs (eg hepcidin, and CATH1 but not CATH2) in HK 436 
cells [25]. The expression of a major APP (eg SAA) and AMPs (eg hepcidin and CATH2) 437 
was positively correlated with the expression of major pro-inflammatory cytokines (Table 438 
S2), suggesting that the activation and release of pro-inflammatory cytokines may lead to the 439 
induction of APPs and AMPs following vaccination. In agreement with this notion, IL-6, that 440 
specific induces CATH2 and hepcidin, was the only up-regulated proinflammatory cytokine 441 
in gills after ERM vaccination, and may account for the high levels of expression of these 442 
two AMPs (Fig. 1).  443 
 444 
4.4 Differential expression of paralogous genes 445 
Many immune genes in teleost fish are known to have multiple paralogues, especially in 446 
salmonids that have undergone an additional whole genome duplication event. For example, 447 
there are three genes for IL-1β and TNF-α in salmonids [21-22] and three each of the p35 and 448 
p40 genes, that potentially could make 9 heterodimeric IL-12 isoforms with different 449 
functions [26-27]. Thus, it is necessary to determine whether all of the genes present react in 450 
a similar manner. In this study it is clear that major differences occur between different 451 
paralogues in response to vaccination. The biggest differences were seen when one of the 452 
paralogues was responsive and the other not, as with IL-1β1 and 2 vs IL-1β3, IL-4/13A vs 453 
IL-4/13B1 and 2, IL-10A vs IL-10B, IL-12 p40B2 vs p40B1 and p40C, IL-17A/F1A vs IL-454 
17A/F1B, IL-17A/F2A vs IL-17A/F2B, and SAP1 vs SAP2. Differential responses of 455 
paralogues have been seen in responses to PAMPs [22,33], infection [24,26] and cytokine 456 
stimulation [25-26]. These differences likely reflect differences in the promoters, with some 457 
of the paralogues becoming more or less responsive to particular signalling pathways, 458 
perhaps in particular cell types, or genes that are being pseudogenised. The differential 459 
responses of IL-12 p40 paralogues is of particular interest. Two isoforms of rainbow trout 460 
rIL-12 have been made as recombinant proteins that differ in the p40 chain (ie p40B or p40C). 461 
These proteins can induce IFN-γ expression in HK cells but only the isoform containing 462 
p40C was able to also induce IL-10 [26]. The induction of all α-chains but only one β-chain 463 
(ie p40B2) suggests that specific IL-12 and IL-23 isoforms are produced after ERM 464 
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vaccination that may have different functions (as seen with IL-12 isoforms) critical for a 465 
Th1/Th17 biased response.  466 
 467 
4.5 Implications for vaccine development in fish 468 
Using an efficacious bacterial model vaccine, this study has revealed that host innate 469 
immunity is activated by ERM vaccination as evidenced by the correlated upregulation of 470 
pro- and anti-inflammatory cytokines in the spleen and the systemic increase of APPs and 471 
AMPs. Specific IL-12 members are induced that may drive the Th1/Th17 biased immune 472 
responses observed. As an efficacious vaccine must activate innate immunity and initiate 473 
specific adaptive pathways, the early responses of the set of genes studied here may provide 474 
essential information and function as biomarkers in future vaccine development for fish, 475 
potentially allowing a screening method for vaccine candidates and formulations before more 476 
expensive mortality testing. 477 
4.6 Conclusions 478 
In summary, ERM vaccination immediately activates a balanced inflammatory response with 479 
correlated expression of both pro- and anti-inflammatory cytokines in the spleen. The 480 
increase of pro-inflammatory cytokines may lead to the systemic upregulation of APPs and 481 
AMPs in both spleen and gills. We also observed an upregulation of all the IL-12 cytokine 482 
family α-chains, but only one β-chain (p40B2) which suggests specific IL-12 and IL-23 483 
isoforms with distinct functions might be produced in the spleen of vaccinated fish. Notably 484 
the expression of Th1 cytokines (IFN-γ1-2) and a Th17 cytokine (IL-17A/F1A) were up-485 
regulated and correlated to that of the IL-12 family α-chains, the majority of pro- and anti-486 
inflammatory cytokines, APPs and AMPs. These expression profiles may suggest that ERM 487 
vaccination activates host innate immunity and expression of specific IL-12 and IL-23 488 
isoforms leading to a Th1 and Th17 biased immune response. This study has increased our 489 
understanding of the host immune response to ERM vaccination and the adaptive pathways 490 
involved. The early responses seen may provide useful biomarkers for future vaccine 491 
development in aquaculture.  492 
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Figure legend 733 
Fig. 1 Modulation of the expression of APP and AMP genes in the spleen and gills by 734 
ERM vaccination. Two groups of rainbow trout were vaccinated by ip injection with 735 
AquaVac ERM (red bars) or PBS as control (blue bars). The fish were killed at days 1, 3, 7 736 
and 14, and spleen and gills collected for gene expression analysis by real-time RT-PCR (as 737 
described in the Materials and Methods). Modulated expression was expressed as a fold 738 
change calculated as the mean expression levels in vaccinated fish normalized to that of time-739 
matched controls in the same tissue. The means + SEM of six fish are shown. The relative 740 
significance of a Bonferroni post hoc test after a significant one way-ANOVA between the 741 
vaccinated and control groups at the same time point is shown above/within the bars as: 742 
*p<0.05, and ***p<0.001. 743 
Fig. 2 Modulation of the expression of pro- and anti-inflammatory cytokines and 744 
Foxp3b in spleen by ERM vaccination. Two groups of rainbow trout were vaccinated by ip 745 
injection with AquaVac ERM (red bars) or PBS as control (blue bars). The fish were killed at 746 
day 1, 3, 7 and 14, and spleen and gills collected for gene expression analysis by real-time 747 
PCR (as described in the Materials and Methods). Modulated expression was expressed as a 748 
fold change calculated as the mean expression levels in vaccinated fish normalized to that of 749 
time-matched controls in the same tissue. The means + SEM of six fish are shown. The 750 
relative significance of a Bonferroni post hoc test after a significant one way-ANOVA 751 
between the vaccinated and control groups at the same time point is shown above/within the 752 
bars as: *p<0.05, and ***p<0.001.  753 
Fig. 3 Modulation of the expression of genes associated with T helper cells in spleen by 754 
ERM vaccination. Two groups of rainbow trout were vaccinated by ip injection with 755 
AquaVac ERM (red bars) or PBS as control (blue bars). The fish were killed at day 1, 3, 7 756 
and 14, and spleen and gills collected for gene expression analysis by real-time PCR (as 757 
described in the Materials and Methods). Modulated expression was expressed as a fold 758 
change calculated as the mean expression levels in vaccinated fish normalized to that of time-759 
matched controls in the same tissue. The means + SEM of six fish are shown. The relative 760 
significance of a Bonferroni post hoc test after a significant one way-ANOVA between the 761 
vaccinated and control groups at the same time point is shown above/within the bars as: 762 
*p<0.05, **p< 0.01 and ***p<0.001. 763 
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Fig. 4 Modulation of the expression of subunits of IL-12 family in spleen by ERM 764 
vaccination. Two groups of rainbow trout were vaccinated by ip injection with AquaVac 765 
ERM (red bars) or PBS as control (blue bars). The fish were killed at day 1, 3, 7 and 14, and 766 
spleen and gills collected for gene expression analysis by real-time PCR (as described in the 767 
Materials and Methods). Modulated expression was expressed as a fold change calculated as 768 
the mean expression levels in vaccinated fish normalized to that of time-matched controls in 769 
the same tissue. The means + SEM of six fish are shown. The relative significance of a 770 
Bonferroni post hoc test after a significant one way-ANOVA between the vaccinated and 771 
control groups at the same time point is shown above/within the bars as: *p<0.05, and 772 
***p<0.001.  773 
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Table 1 Primers used for expression analysis by real-time PCR 
Gene ∆cp*(Spleen) ∆cp* (Gills) Forward (5’ to 3’) Reverse  (5’ to 3’) Acc. No. 
House-keeping gene 
EF-1α 0** 0** CAAGGATATCCGTCGTGGCA ACAGCGAAACGACCAAGAGG AF498320  
Acute phase proteins and antimicrobial peptides 
SAA 8.16 8.34 GGTGAAGCTGCTCAAGGTGCTAAAG GCCATTACTGATGACTGTTGCTGC AM422447 
SAP1 20.43 21.17 GCTGTTATGGTGACCTTCAAGATCTCTC GCGTTTGTACAACAACAAATCATTGTC X99385 
SAP2 15.08 13.91 GGTTGTTATGCTGAACATCAAGATCTCTC CCACCCTTTGATTGCATACACAGATT EZ763346 
CATH1 9.39 9.14 ACCAGCTCCAAGTCAAGACTTTGAA TGTCCGAATCTTCTGCTGCAA AY594646 
CATH2 11.77 11.00 ACATGGAGGCAGAAGTTCAGAAGA GAGCCAAACCCAGGACGAGA AY542963 
Hepcidin 11.73 16.19 GCTGTTCCTTTCTCCGAGGTGC GTGACAGCAGTTGCAGCACCA CA369786 
LEAP2A 12.19 12.91 GGTTCCTGGTGTTTCTGGTGCT AGTGGCCACCCCTGCAAAT AY362186 
β-defensin-1 17.99 19.57 CTGGTTTTCCTATTGCTTAATGTTGTGG GAAATGAGAAACACAGCACAAGAATCC AM282655 
β-defensin-2 17.77 20.22 ATGGGGAGACTGGGTTTGGT ACGCAAAGCACAGCATCTTAATCT FM212656 
β-defensin-3 17.96 24.42 GGCTCTTTTAGTCATTGCTTGTGGAATAC CAGCATACATTCGGCCATGTACA FM212657 
β-defensin-4 20.58 18.13 TGGTGCTCCTCGCTTTCTTGG TGGGCGACACAGCATACAAATC FM212658 
Cytokines 
IL-1β1 10.26 11.51 CCTGGAGCATCATGGCGTG GCTGGAGAGTGCTGTGGAAGAACATATAG AJ278242 
IL-1β2 20.89 14.09 GAGCGCAGTGGAAGTGTTGG AGACAGGTTCAAATGCACTTTATGGT AJ245925 
IL-1β3 11.18 11.77 CTG AAG GCC GTC ACA ATC CA CTGGTCCTTACAGCGCTCCAA AM181685 
nIL-1Fm 10.04 9.41 CCCATTCCTCGTGACACCAG CTGGACGACCTGGAGAGTGACT AJ555869 
IL-2 13.45 14.43 TGATGTAGAGGATAGTTGCATTGTTGC GAAGTGTCCGTTGTGCTGTTCTC AM422779 
IL-4/13A 13.96 12.12 ACCACCACAAAGTGCAAGGAGTTCT CACCTGGTCTTGGCTCTTCACAAC FN820501 
IL-4/13B1 17.21 13.28 GAGATTCATCTACTGCAGAGGATCATGA GCAGTTGGAAGGGTGAAGCTTATTGTA HG794522 
IL-4/13B2 18.55 15.87 GAGACTCATCTATTGCGTATGATCATCG TGCAGTTGGTTGGATGAAACTTATTGTA HG794523 
IL-6 14.45 18.56 GGGAGAAAATGATCAAGATGCTCGT GCAGACATGCCTCCTTGTTGG DQ866150  
IL-8 9.58 8.72 AGAGACACTGAGATCATTGCCAC CCCTCTTCATTTGTTGTTGGC  AJ310565   
IL-10A 16.55 13.68 GGATTCTACACCACTTGAAGAGCCC GTCGTTGTTGTTCTGTGTTCTGTTGT AB118099 
IL-10B 16.90 15.50 GGGATTCTAGACCACATCAAGAGTCC GATGGGAGATTTAAAGTTGTGTGTTCC FR691804 
IL-11 10.86 14.38 CTCTCGCTGCTATTGGCCCA TCTCGAATGCATGTTCCTTCAATAGAT AJ535687  
M17 12.14 10.58 GTGGACCTCTTAAAAACATACAAGCTCAG GGATGGTGGCTGTAAGTCTGTCTG FM866399 
IL-12 p35A1 16.62 17.51 GGAACACCACATTCAGTGAGAGTGC CGTCTGCAACTTGTGAGGAAGGAT HE798148 
IL-12 p35A2 20.73 19.77 GGAACACCACATTCAGTGAGAGTGA CAACCTGTGAGGAAGACACCCA HG917950  
IL-12 p35B1 21.49 18.58 TGCCAAACGCCAAGCTTTATTTTG GCTGTTGAGTGCTTTTGGTCTTTGG HG917951 
IL-12 p40B1 17.14 9.77 CCCTTCTACATCCGAGAAATAGTGAAAC GTTGGTTTCACTTATAAACACCTTTTCCTT HE798149 
IL-12 p40B2 14.14 9.46 CCGTTCTACATACGAGAAATAGTGGAGA TCAGAGTCACAGCTTTCCCTGG HG917952 
IL-12 p40C 12.14 12.13 TTAAAGACAACGGAAAGGAGGAGC CCTCCCGTAACCACATTTTTCC AJ548830 
IL-23 p19 22.01 16.44 ACCTAAGAGCAGATTCAATGCCTTG TCTTCCCAGCTCTTCACTTCCTG KP410548  
IL-27 p28A 19.88 18.47 GCAGCTGCTCAGGAGATATAAGGAGG TCTCTCAGGTATGCTGGGTTTTGG HG794528 
IL-27 p28B 22.39 22.06 GCAGCTGCTCATGAGATATAAAGAGGA GCTGCTCTCTGTTCCACCTTATCCAC HG794529 
EBI3 17.27 17.42 ACATCGCCACCTACAGTATGAAAGG GGGTCCGGCTTCACAATGT  AJ620467 
IL-15 7.95 7.69 TGGAATTGCTTCATAATATTGAGCTGCC TGGTAGTTATCTGTGACCGACATGTCCTC AJ628345   
IL-17A/F1A 24.36 13.42 CAAACGTACACTTTTTGATGGTGCTG GGGACTCATCATAGGTGGTGTTGGT  KJ921977  
IL-17A/F1B 18.92 20.46 CTTCCAGTCTTTGACGGTGCTG GGTTGTAAATAGGTCTGATGGAATGGAA KJ921978 
IL-17A/F2A 20.94 11.97 CACCCTGGACCTGGAAAAGCAC GGCCACAGACAGGAAGGAGG AJ580842 
IL-17A/F2B 22.62 18.05 CCCTGGACCTGGAAACCCAT GGCCACGGACAGGAAGGTGA KJ921979 
IL-17A/F3 18.89 11.41 CTGGTGCTGGGTCTGATCATGT GGTCTCATCGTATGTGTCGCTGTATG KJ921980 
IL-17A/F4/N 25.20 18.46 AGAACTCAACATGCAACAGCTCCA  CGGTTCAAGTCAATTTTTTCCACGTA KJ921981 
IL-17C1 22.60 15.21 CTGGCGGTACAGCATCGATA GAGTTATATCCATAATCTTCGTATTCGGC FM955455 
IL-17C2 16.84 16.70 CTGGCGGTACAGCATCGATA CAGAGTTATATGCATGATGTTGGGC FM955456 
IL-17D 19.30 11.10 GAAGAAATCCTCGAGCAGATGTTTG GGGTCGTGGGAGATCCTGTATG AJ580843 
IL-18 9.02 10.01 GAGCAATGCAAAGCAGATGATTG CATGTTTTGAGCAGCCAATGTAGTC AJ556990 
IL-20 >25 19.37 CAAGAACCTGAGGCAATGTCACTG TCTCCTATAGCCTTTACTGCTGCCG FN386780 
IL-21 16.45 15.00 AAAGTTATCAAAAACCTCAACAACCGAA  CCAGTCTACTGATGGCCTTTTGAAG FM883702 
IL-22 18.05 12.20 GAAGGAACACGGCTGTGCTATTAAAC GATCTAGGCGTGCACACAGAAGTC AM748538  
IL-34 9.97 9.31 AGGCAGAAGACGTAACATGAAACACA TCCACCCTCGCCCTCAGCTT FN820429 
IFNγ1 12.41 12.16 CAAACTGAAAGTCCACTATAAGATCTCCA TCCTGAATTTTCCCCTTGACATATTT AJ616215 
IFNγ2 14.43 14.00 CAAACTGAAAGTCCACTATAAGATCTCCA GGTCCAGCCTCTCCCTCAC FM864345 
TGF-β1A 8.13 9.90 CTCACATTTTACTGATGTCACTTCCTGT GGACAACTGCTCCACCTTGTG OMY7836  
TGF-β1B 7.47 8.72 CATGTCCATCCCCCAGAACT GGACAACTGTTCCACCTTGTGTT FN822750 
  13.09 13.29 TGTGTGGGGTCCTCTTAATAGCAGGTC CCTCAATTTCATCCTGCATCGTTGA AJ277604 
TNF-α2 16.03 14.35 CTGTGTGGCGTTCTCTTAATAGCAGCTT CATTCCGTCCTGCATCGTTGC AJ401377 
TNF-α3 14.94 16.51 GCTGCACTCTTCTTTACCAAGAAACAAG  CCACTGAGGACTTGTAATCACCATAGGT HE798544 
Master transcription factors 
T-bet 11.09 14.89 GGTAACATGCCAGGGAACAGGA TGGTCTATTTTTAGCTGGGTGATGTCTG FM863825 
GATA3 11.12 5.29 CCAAAAACAAGGTCATGTTCAGAAGG TGGTGAGAGGTCGGTTGATATTGTG FM863826 
RORγ*** 9.04 8.61 ACAGACCTTCAAAGCTCTTGGTTGTG GGGAAGCTTGGACACCATCTTTG FM883712 
Foxp3A 9.78 10.42 CCCAGAACCGAGGTGGAGTGT TGACGGACAGCGTTCTTCCA FM883710  
Foxp3B 9.09 9.99 TCCTGCCCCAGTACTCATCCC  TGACGGACAGCGTTCTTCCA FM883711 
 
Notes 
*∆cp is the average cp value of the target gene minus that of the house-keeping gene EF-1α in the control fish at day 1 post vaccination. A 
higher ∆cp value indicates a lower expression level.  
**The average cp of EF-1α is 11.31+0.25 (spleen) and 10.44+0.11 (gills).  
***Primers amplify both RORγa and RORγb genes. 
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Table 2 Fold change of transcript expression of studied genes in spleen after ERM vaccination not shown in Figs 1-
4. Asterisks indicate significant differences between vaccinated fish and controls as **p<0.01 and ***p<0.001 (One-
way-ANOVA with Bonferroni correction).  
 
 
 
 
 
Gene D1 D3 D7 D14 
LEAP2A 0.58 0.53 0.81 0.22 
β-defensin-1 0.14 0.27 0.27 0.21 
β-defensin-2 2.57 0.35 0.17 1.07 
β-defensin-3 1.25 0.43 0.46 0.41 
β-defensin-4 1.68 0.75 0.73 0.48 
IL-1β3 1.11 1.22 0.95 0.92 
IL-10B 1.33 0.67 0.59 0.62 
IL-12 p40B1 1.21 0.84 0.66 1.41 
IL-12 p40C 1.08 0.77 1.34 1.56 
IL-27 p28B 11.06*** 2.16 0.44 0.99 
EBI3 0.75 0.48 1.45 1.38 
IL-15 1.65 0.99 0.72 0.86 
IL-17A/F1b 5.90 4.44 3.09 0.58 
IL-17A/F2b 1.41 3.00 0.38 1.78 
IL-17A/F4/N 15.95 0.97 3.15 4.52 
IL-17C1 2.93 2.00 1.21 0.68 
IL-17C2 1.48 2.00 0.82 1.52 
IL-17D 0.50 0.29** 0.48 0.32 
IL-18 1.72*** 1.10 0.70 0.82 
IL-20 1.66 0.24 0.04 0.37 
IL-21 2.51** 0.61 1.18 1.49 
IL-22 1.97 2.24 0.84 1.02 
IL-34 1.59 0.52 0.69 1.04 
TGF-β1A 1.42 1.07 0.83 0.81 
TGF-β1B 2.43 0.74 0.58 0.48 
Foxp3A 0.43*** 0.74 1.26 0.76 
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Table 3. The Spearman’s rho correlation coefficient (R) and the 2-tailed significance (p) between gene expression levels of the pro and anti-inflammatory 
cytokines in the spleen of vaccinated fish at day 1 and day 3 post-injection. R in bold suggests a significant Spearman rank ordered correlation. 
  
  
IL-1β1 IL-1β2 TNF-α1 TNF-α2 TNF-α3 IL-8 IL-6 IL-11 M17 IL-18 IL-21 nIL-1Fm IL-10A 
IL-1β1 R 1.000 0.925 0.846 0.907 0.949 0.954 0.818 0.939 0.837 0.415 0.724 0.905 0.691 
  
p 
  .000 .001 .000 .000 .000 .001 .000 .001 .180 .008 .000 .013 
IL-1β2 R 0.925 1.000 0.774 0.811 0.888 0.872 0.799 0.806 0.768 0.439 0.544 0.774 0.600 
  
p 
.000   .003 .001 .000 .000 .002 .002 .004 .154 .068 .003 .039 
TNF-α1 R 0.846 0.774 1.000 0.870 0.809 0.847 0.882 0.821 0.747 0.668 0.789 0.902 0.499 
  
p 
.001 .003   .000 .001 .001 .000 .001 .005 .018 .002 .000 .099 
TNF-α2 R 0.907 0.811 0.870 1.000 0.895 0.912 0.891 0.947 0.863 0.627 0.704 0.924 0.613 
  
p 
.000 .001 .000   .000 .000 .000 .000 .000 .029 .011 .000 .034 
TNF-α3 R 0.949 0.888 0.809 0.895 1.000 0.907 0.855 0.904 0.853 0.519 0.723 0.865 0.656 
  
p 
.000 .000 .001 .000   .000 .000 .000 .000 .084 .008 .000 .020 
IL-8 R 0.954 0.872 0.847 0.912 0.907 1.000 0.823 0.94 0.896 0.508 0.780 0.949 0.779 
  
p 
.000 .000 .001 .000 .000   .001 .000 .000 .092 .003 .000 .003 
IL-6 R 0.818 0.799 0.882 0.891 0.855 0.823 1.000 0.828 0.787 0.724 0.747 0.830 0.599 
  
p 
.001 .002 .000 .000 .000 .001   .001 .002 .008 .005 .001 .039 
IL-11 R 0.939 0.806 0.821 0.947 0.904 0.940 0.828 1.000 .903
**
 0.485 0.743 0.961 0.745 
  p 
.000 .002 .001 .000 .000 .000 .001   .000 .110 .006 .000 .005 
M17 R 0.837 0.768 0.747 0.863 0.853 0.896 0.787 0.903 1.000 0.465 0.669 0.907 0.861 
  p 
.001 .004 .005 .000 .000 .000 .002 .000   .128 .017 .000 .000 
IL-18 R 0.415 0.439 0.668 0.627 0.519 0.508 0.724 0.485 0.465 1.000 0.428 0.589 0.165 
  p 0.180 .154 .018 .029 .084 .092 .008 .110 .128   .165 .044 .607 
IL-21 R 0.724 0.544 0.789 0.704 0.723 0.780 0.747 0.743 0.669 0.428 1.000 0.782 0.613 
  
p 
.008 .068 .002 .011 .008 .003 .005 .006 .017 .165   .003 .034 
nIL-1Fm R 0.905 0.774 0.902 0.924 0.865 0.949 0.830 0.961 0.907 0.589 0.782 1.000 0.731 
  
p 
.000 .003 .000 .000 .000 .000 .001 .000 .000 .044 .003   .007 
IL-10A R 0.691 0.600 0.499 0.613 0.656 0.779 0.599 0.745 0.861 0.165 0.613 0.731 1.000 
  
p 
.013 .039 .099 .034 .020 .003 .039 .005 .000 .607 .034 .007   
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Table 4. The Spearman’s rho correlation coefficient (R) and the 2-tailed significance (p) between gene expression levels of the cytokines involved in Th cell 
development in the spleen of vaccinated fish at day 1 and day 3 post-injection. R in bold suggests a significant Spearman rank ordered correlation. 
    IFNγ1 IFNγ2 
IL-
17A/F1A 
IL-
17A/F2A 
IL-
17A/F3 
IL-
4/13B1 
IL-
4/13B2 P35A1 P35A2 P35B1 P19 P28A P28B P40B2 
IFNγ1 R 1.000 0.830 0.904 0.564 0.753 0.011 0.652 0.605 0.840 0.775 0.789 0.881 0.793 0.385 
  p   .001 .000 .056 .005 .974 .022 .037 .001 .003 .002 .000 .002 .217 
IFNγ2 R 0.830 1.000 0.741 0.394 0.720 -0.014 0.425 0.845 0.839 0.900 0.646 0.715 0.620 0.456 
  p .001   .006 .205 .008 .966 .169 .001 .001 .000 .023 .009 .032 .136 
IL-17A/F1A R 0.904 0.741 1.000 0.528 0.755 -0.210 0.386 0.694 0.86 0.609 0.877 0.904 0.830 0.186 
  p .000 .006   .078 .005 .513 .215 .012 .000 .035 .000 .000 .001 .563 
IL-17A/F2A R 0.564 0.394 0.528 1.000 0.500 0.127 0.534 0.397 0.682 0.473 0.530 0.490 0.215 -0.223 
  p .056 .205 .078   .098 .695 .074 .201 .015 .121 .076 .106 .502 .487 
IL-17A/F3 R 0.753 .720** 0.755 0.500 1.000 0.168 0.498 0.528 0.670 0.529 0.523 0.578 0.420 0.102 
  p .005 .008 .005 .098   .602 .099 .078 .017 .077 .081 .049 .174 .753 
IL-4/13B1 R 0.011 -0.014 -0.210 0.127 0.168 1.000 0.491 -0.412 -0.021 0.018 -0.453 -0.298 -0.347 0.207 
  p .974 .966 .513 .695 .602   .105 .183 .948 .957 .140 .347 .269 .519 
IL-4/13B2 R 0.652 0.425 0.386 0.534 0.498 0.491 1.000 0.002 0.465 0.475 0.151 0.290 0.246 0.401 
  p .022 .169 .215 .074 .099 .105   .996 .128 .119 .639 .361 .441 .196 
P35A1 R 0.605 0.845 0.694 0.397 0.528 -0.412 0.002 1.000 0.795 0.762 0.746 0.691 0.550 0.102 
  p .037 .001 .012 .201 .078 .183 .996   .002 .004 .005 .013 .064 .751 
P35A2 R 0.840 0.839 0.860 0.682 0.670 -0.021 0.465 0.795 1.000 0.830 0.759 0.779 0.608 0.155 
  p .001 .001 .000 .015 .017 .948 .128 .002   .001 .004 .003 .036 .631 
P35B1 R 0.775 0.900 0.609 0.473 0.529 0.018 0.475 0.762 0.830 1.000 0.624 0.646 0.460 0.290 
  p .003 .000 .035 .121 .077 .957 .119 .004 .001   .030 .023 .133 .361 
P19 R 0.789 0.646 0.877 0.530 0.523 -0.453 0.151 0.746 0.759 0.624 1.000 0.942 0.780 0.030 
  p .002 .023 .000 .076 .081 .140 .639 .005 .004 .030   .000 .003 .926 
P28A R 0.881 0.715 0.904 0.490 0.578 -0.298 0.290 0.691 0.779 0.646 0.942 1.000 0.896 0.262 
  p .000 .009 .000 .106 .049 .347 .361 .013 .003 .023 .000   .000 .411 
P28B R 0.793 0.620 0.830 0.215 0.420 -0.347 0.246 0.550 0.608 0.460 0.780 0.896 1.000 0.513 
  p .002 .032 .001 .502 .174 .269 .441 .064 .036 .133 .003 .000   .088 
p40B2 R 0.385 0.456 0.186 -0.223 0.102 0.207 0.401 0.102 0.155 0.290 0.030 0.262 0.513 1.000 
  p .217 .136 .563 .487 .753 .519 .196 .751 .631 .361 .926 .411 .088   
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Table 5 Comparison of gene expression modulated by ERM vaccination and Y. ruckeri infection in the 
spleen and gills of rainbow trout. “↑” = up-regulation, “↓”=down regulation and “-” = no change. 
 
 
Gene 
ERM vaccination Y. ruckeri infection 
 Spleen Gills Spleen Gills 
SAA ↑ ↑ ↑ [9,36 ]  
SAP1 ↑ - ND ND 
SAP2 - - ND ND 
CATH1 ↑ - ND ND 
CATH2 ↑ ↑ ↑ [9] ND 
Hepcidin ↑ ↑ ND ND 
LEAP2A - - ND ND 
β-defensin-1 - - ND - [38] 
β-defensin-2 - - ND - [38] 
β-defensin-3 - - ND ↑ [38] 
β-defensin-4 - - ND - [38] 
IL-1β1 ↑ - ↑ [9,17,36,45,62] ↑[ 17] 
IL-1β2 ↑ - ↑ [45] ND 
IL-1β3 - - ND ND 
nIL-1Fm ↑ - ↑ [45] ND 
IL-2 - - ↑[17,50] ↑[17,50] 
IL-4/13A - - - [9] ↓[25] 
IL-4/13B1 ↑ - ND ↓[25] 
IL-4/13B2 ↑ - ND ↓[25] 
IL-6 ↑ ↑ ↑ [9,17,59] ↑ [17] 
IL-8 ↑ - [60]  
IL-10A ↑ - ↑ [9,17,59] ↑ [17] 
IL-10B - - - [ 42] ↑[17] 
IL-11 ↑ - ↑ [17,59] ↑ [17] 
M17 ↑ - ↑ [45] ND 
IL-12 p35A1 ↑ - ↑ [26] ND 
IL-12 p35A2 ↑ - ND ND 
IL-12 p35B1 ↑ - ND ND 
IL-12 p40B1 - - ↑ [26] ND 
IL-12 p40B2 ↑ - ND ND 
IL-12 p40C - - ↑ [26] ND 
IL-23 p19 ↑ - ↑ [28] ND 
IL-27 p28A ↑ - ND ND 
IL-27 p28B ↑ - ND ND 
EBI3 - - ND ND 
IL-15 - - ND ND 
IL-17A/F1A ↑ - ↑ [24] - [24] 
IL-17A/F1B - - - [24] - [24] 
IL-17A/F2A ↑ - ↑ [23-24] - [24] 
IL-17A/F2B - - - [24] - [24] 
IL-17A/F3 ↑ - ↑ [24] - [24] 
IL-17A/F4/N - - ↑ [24] - [24] 
IL-17C1 - - ↑ [53] ND 
IL-17C2 - - ↑ [53] ND 
IL-17D ↓ - ND ND 
IL-18 ↑ - ND ND 
IL-20 - - ↑ [54] ND 
IL-21 ↑ - ↑ [31] ND 
IL-22 - - ↑ [17,55] ↑ [17] 
IL-34 - - ND ND 
IFNγ1 ↑ - ↑ [9,17,36,59] ↑ [17]  
IFNγ2 ↑ - ND ND 
TGF-β1A - - ↑ [17,36] ↑ [17] 
TGF-β1B - - ND ND 
TNF-α1 ↑ - ↑ [9,36] ↑ [17] 
TNF-α2 ↑ - ↑ [17,22] ↑ [17] 
TNF-α3 ↑ - ↑ [22]  
T-bet - - ↓ [17,47],  ↑  [9] ↑ [17] 
GATA3 - - ↓ [9,17,48] ↑ [17] 
RORγ - - ↑ [49] ↑ [49] 
Foxp3A - - ND ND 
Foxp3B ↓ - ND ND 
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Highlights 
 
 
 ERM vaccination activates both pro- and anti-inflammatory cytokine expression in 
spleen. 
 ERM vaccination upregulates APP and AMP expression in both spleen and gills. 
 ERM vaccination induces the expression of specific IL-12 and IL-23 isoforms in spleen. 
 ERM vaccination initiates a Th1/Th17 biased immune response in spleen. 
